Aligning Glytec's Solutions with Value-Based Reforms

Andrew Rhinehart, MD, FACP, FACE, CDE, BC-ADM, CDTC

American Diabetes Association Scientific Sessions, June 2017

Dr. Andrew Rhinehart, Chief Medical Officer at Glytec, discusses how Glytec's product strategy aligns with value-based reforms by addressing the needs of patients with diabetes across the entire continuum -- all settings and transitions of care.

Data Sharing for Diabetes Therapy Management

Robby Booth

American Diabetes Association Scientific Sessions, June 2017

Robby Booth, Senior Vice President Research & Development at Glytec, discusses data sharing capabilities with connected device partners such as AgaMatrix, Livongo and Telcare, and the benefits to patients and providers of applying decision support algorithms for more efficient and timely insulin dosing recommendations.

Evidence Strategy for Diabetes Outcomes

Andrew Rhinehart, MD, FACP, FACE, CDE, BC-ADM, CDTC

American Diabetes Association Scientific Sessions, June 2017

Dr. Andrew Rhinehart, Chief Medical Officer at Glytec, discusses a transition in evidence strategy that translates intermediate outcomes, such as hypoglycemia and hyperglycemia, to "hard outcomes," such as lengths of stay, readmissions, infections and costs of care.

Shifting to Basal Bolus Best Practice with eGMS

Raymie McFarland, SSGB

American Diabetes Association Scientific Sessions, June 2017

Raymie McFarland, Vice President Quality Initiatives at Glytec, discusses how the eGlycemic Management System helped Kaweah Delta Medical Center shift from sliding scale insulin to basal bolus insulin, recommended as best practice by the American Association of Clinical Endocrinologists (AACE) and American Diabetes Association (ADA).

ArrowArrow
AJMC Interviews Dr. Andrew Rhinehart
Aligning Glytec's Solutions with Value-Based Reforms
AJMC Interviews Robby Booth
Data Sharing for Diabetes Therapy Management
AJMC Interviews Dr. Andrew Rhinehart
Evidence Strategy for Diabetes Outcomes
AJMC Interviews Raymie McFarland
Shifting to Basal Bolus Best Practice with eGMS

Aligning Glytec's Solutions with Value-Based Reforms

Andrew Rhinehart, MD, FACP, FACE, CDE, BC-ADM, CDTC

American Diabetes Association Scientific Sessions, June 2017

Dr. Andrew Rhinehart, Chief Medical Officer at Glytec, discusses how Glytec's product strategy aligns with value-based reforms by addressing the needs of patients with diabetes across the entire continuum -- all settings and transitions of care.

Data Sharing for Diabetes Therapy Management

Robby Booth

American Diabetes Association Scientific Sessions, June 2017

Robby Booth, Senior Vice President Research & Development at Glytec, discusses data sharing capabilities with connected device partners such as AgaMatrix, Livongo and Telcare, and the benefits to patients and providers of applying decision support algorithms for more efficient and timely insulin dosing recommendations.

Evidence Strategy for Diabetes Outcomes

Andrew Rhinehart, MD, FACP, FACE, CDE, BC-ADM, CDTC

American Diabetes Association Scientific Sessions, June 2017

Dr. Andrew Rhinehart, Chief Medical Officer at Glytec, discusses a transition in evidence strategy that translates intermediate outcomes, such as hypoglycemia and hyperglycemia, to "hard outcomes," such as lengths of stay, readmissions, infections and costs of care.

Shifting to Basal Bolus Best Practice with eGMS

Raymie McFarland, SSGB

American Diabetes Association Scientific Sessions, June 2017

Raymie McFarland, Vice President Quality Initiatives at Glytec, discusses how the eGlycemic Management System helped Kaweah Delta Medical Center shift from sliding scale insulin to basal bolus insulin, recommended as best practice by the American Association of Clinical Endocrinologists (AACE) and American Diabetes Association (ADA).

ArrowArrow
AJMC Interviews Dr.Andrew Rhinehart
Aligning Glytec's Solutions with Value-Based Reforms
AJMC Interviews Robby Booth
Data Sharing for Diabetes Therapy Management
AJMC Interviews Dr. Andrew Rhinehart
Evidence Strategy for Diabetes Outcomes
AJMC Interviews Raymie McFarland
Shifting to Basal Bolus Best Practice with eGMS
Request Demo